We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EMA Form Pharmacovigilance ‘Cluster’ to Speed Drug Safety Responses
FDA, EMA Form Pharmacovigilance ‘Cluster’ to Speed Drug Safety Responses
The FDA and European Medicines Agency (EMA) have launched a new information-sharing initiative they hope will coordinate and speed international responses to drug safety problems.